1-(4-氯苯基)-2-吡咯烷酮 | 7661-33-8

• 物质功能分类: 有机原料 - 杂环化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯烷类
• 中文名称: 1-(4-氯苯基)-2-吡咯烷酮
• 英文名称: 1-(4-chlorophenyl)pyrrolidin-2-one
• 英文别名: 1-(4-Chlorophenyl)-2-pyrrolidinone
• CAS: 7661-33-8
• 化学式: C₁₀H₁₀ClNO
• mdl: MFCD00138486
• 分子量: 195.648
• InChiKey: NAIVIVMHCDWBEF-UHFFFAOYSA-N

物化性质

• 熔点：
  95-98 °C
• 密度：
  1.1683 (rough estimate)

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  20.3
• 氢给体数：
  0
• 氢受体数：
  1

安全信息

• 危险等级：
  IRRITANT
• 安全说明：
  S24/25
• 海关编码：
  2933790090
• 危险性防范说明：
  P261,P280,P301+P312,P302+P352,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335
• 储存条件：
  室温下，样品应保存在惰性气体环境中。

SDS

Name:	1-(4-Chlorophenyl)-2-pyrrolidinone 99+% Material Safety Data Sheet
Synonym:	None
CAS:	7661-33-8

Section 1 - Chemical Product MSDS Name:1-(4-Chlorophenyl)-2-pyrrolidinone 99+% Material Safety Data Sheet
Synonym:None

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
7661-33-8	1-(4-Chlorophenyl)-2-pyrrolidinone	>99	unlisted

Hazard Symbols: None Listed.
Risk Phrases: None Listed.

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. The toxicological properties of this substance have not been fully investigated. May be harmful if swallowed.
Inhalation:
May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated. May be harmful if inhaled.
Chronic:
No information found.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Runoff from fire control or dilution water may cause pollution.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or appropriate foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.

---

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use with adequate ventilation. Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid breathing dust.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 7661-33-8: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Crystals
Color: light beige
Odor: None reported.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 95-98 deg C
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C10H10ClNO
Molecular Weight: 195.65

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Dust generation, excess heat.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Hydrogen chloride, nitrogen oxides, carbon monoxide, irritating and toxic fumes and gases, carbon dioxide.
Hazardous Polymerization: Has not been reported.

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 7661-33-8 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
1-(4-Chlorophenyl)-2-pyrrolidinone - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing Group:
IMO
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing Group:
RID/ADR
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing group:

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 7661-33-8: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 7661-33-8 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 7661-33-8 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  1-(4-氯苯基)-2-吡咯烷酮 在 p-nitrobenzenesulfonyl azide 、 dirhodium tetraacetate 、 sodium hydride 、 1,8-二氮杂双环[5.4.0]十一碳-7-烯 作用下， 以 四氢呋喃 、 二氯甲烷 、 mineral oil 为溶剂， 反应 6.92h， 生成 1-(4-chlorophenyl)-3-methoxypyrrolidin-2-one
  参考文献：
  名称：

  α-重氮γ-丁内酰胺的合成探索

  摘要：

  迄今为止，已经从各自的内酰胺制备了探索不佳的α-重氮-γ-丁内酰胺（使用α-乙氧基化方案），并在各种反应中进行了研究（例如在AgOTf和Rh 2（OAc）4催化下重氮功能消除和OH插入）， 分别]。如果氮原子上的取代基有效地与羰基结合，则这些化合物是稳定的。

  DOI：

  10.1002/ejoc.201900133
• 作为产物：
  描述：

  4-chloro-N-(4-chlorophenyl)butyramide 在 potassium carbonate 、 N-甲基苄胺 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 12.0h， 以67%的产率得到1-(4-氯苯基)-2-吡咯烷酮
  参考文献：
  名称：

  苯甲酰胺衍生物作为有效和选择性sigma-1蛋白配体的合成和药理评价

  摘要：

  设计，合成和药理学评估了一系列新颖的苯甲酰胺衍生的化合物。在所有37种合成化合物中，开发了两个系列，调节了苯甲酰胺骨架上原子或基团的性质，位置，以及从具有2、3或4个亚甲基的苯甲酰胺中分离出来的胺基的性质。针对sigma蛋白（sigma-1 S1R和sigma-2 S2R）的体外竞争结合试验表明，它们中的大多数赋予S2R / S1R选择性，而对SY5Y细胞无细胞毒性作用，特别是在第一个化合物7a-z的情况下。还评估了一些选定的化合物在40种受体上的激动剂和拮抗剂活性。结果表明，在苯甲酰胺支架上，其性质和与卤代原子的位置，长度链以及疏水部分对胺基的贡献至关重要。其中，在苯甲酰胺支架的4位带有Cl，CN或NO 2基团的化合物7i，w，y对S1R表现出优异的亲和力（Ki  = 1.2–3.6 nM），对S2R的选择性（Ki高达1400 nM）和高选择性指数（IC 50（SY5Y） / Ki （S1R）

  DOI：

  10.1016/j.ejmech.2017.07.014

文献信息

• Scope and selectivity in palladium-catalyzed directed C–H bond halogenation reactions
  作者：Dipannita Kalyani、Allison R. Dick、Waseem Q. Anani、Melanie S. Sanford

  DOI：10.1016/j.tet.2006.06.075

  日期：2006.12

  Palladium-catalyzed ligand directed C–H activation/halogenation reactions have been extensively explored. Both the nature of the directing group and the substitution pattern on the arene ring of the substrate lead to different reactivity profiles, and often different and complementary products, in the presence and absence of the catalyst.

  钯催化的配体定向的C–H活化/卤化反应已得到广泛研究。在存在和不存在催化剂的情况下，导向基团的性质和底物的芳环上的取代图案均导致不同的反应性分布，并且常常导致不同的和互补的产物。
• Rhodium(III)-Catalyzed C-H Vinylation of Arenes: Access to Functionalized Styrenes
  作者：Jun Zhou、Xin Li、Gang Liao、Bing-Feng Shi

  DOI：10.1002/cjoc.201800354

  日期：2018.12

  An effective method has been developed for Rh(III)‐catalyzed direct vinylation of arenes to give functionalized styrenes, using vinyltriethoxysilane as a convenient and inexpensive vinyl source. A wide variety of substrates, including 1‐aryl‐2‐pyrrolidinones, anilines, benzamides and ketones, were compatible with this reaction. Moreover, this method can be applied to the two‐step synthesis of functionalized

  已开发出一种有效的方法，可使用乙烯基三乙氧基硅烷作为方便，廉价的乙烯基来源，对Rh（III）催化的芳烃进行直接乙烯基化，以生成官能化的苯乙烯。此反应兼容多种底物，包括1-芳基-2-吡咯烷酮，苯胺，苯甲酰胺和酮。而且，该方法可以应用于功能化吲哚的两步合成。机理研究表明该反应可能通过氧化性Heck /去甲硅烷基化途径进行。
• Mild and Efficient Cobalt-Catalyzed Cross-Coupling of Aliphatic Amides and Aryl Iodides in Water
  作者：Yong-Chua Teo、Bryan Tan

  DOI：10.1055/s-0034-1380724

  日期：——

  convenient protocol for the C–N cross-coupling of aliphatic amides and iodobenzene is demonstrated using a simple and inexpensive Co(C2O4)·2H2O/N,N′-dimethylethylenediamine (DMEDA) catalytic system in water. Good yields of N-arylated products were isolated (up to 85%) and the protocol has been successfully applied to the synthesis of the anticancer drug, flutamide.

  使用简单且廉价的 Co(C2O4)·2H2O/N,N'-二甲基乙二胺 (DMEDA) 催化体系在水中证明了脂肪族酰胺和碘苯的 C-N 交叉偶联的便捷方案。分离出高产率的 N-芳基化产物（高达 85%），该方案已成功应用于抗癌药物氟他胺的合成。
• 一种吡咯烷酮类化合物的合成方法
  申请人：河南师范大学

  公开号：CN109369495B

  公开（公告）日：2021-08-06

  本发明公开了一种吡咯烷酮类化合物的合成方法，属于有机合成技术领域。将饱和环状叔胺1加入溶剂中，在氧化剂：二价铜盐、过硫酸氢钾复合盐(Oxone)和氧气的混合物等和添加剂：碘单质或碘化金属盐等存在下，加热反应制得吡咯烷酮2；该方法通过饱和环状叔胺类化合物的氧化缩环、脱羰和原位氧化等串联反应合成了吡咯烷酮类化合物，具有操作简便、条件温和、底物适用范围广等优点，为吡咯烷酮类化合物的合成提供了一种经济实用且绿色环保的新方法。
• Selective synthesis of pyrrolidin-2-ones and 3-iodopyrroles <i>via</i> the ring contraction and deformylative functionalization of piperidine derivatives
  作者：Fang Wang、Xinying Zhang、Yan He、Xuesen Fan

  DOI：10.1039/c8ob02640h

  日期：——

  In this paper, a selective synthesis of pyrrolidin-2-ones and 3-iodopyrroles via the cascade reactions of N-substituted piperidines is presented. Mechanistically, the formation of pyrrolidin-2-ones involves a domino process including the in situ formation of pyrrolidine-2-carbaldehyde followed by carboxylic acid formation, decarboxylation and ipso-oxidation. On the other hand, 3-iodopyrroles are believed

  在本文中，提出了通过N-取代的哌啶的级联反应选择性合成吡咯烷酮-2-酮和3-碘吡咯的方法。从机理上讲，吡咯烷-2-酮的形成涉及一个多米诺过程，包括原位形成吡咯烷-2-甲醛，然后形成羧酸，脱羧和ipso-氧化。另一方面，据信3-碘吡咯是通过首先生成吡咯烷-2-甲醛，然后形成羧酸，脱羧，脱氢，碘化和芳构化。有趣的是，可以从相同的底物选择性地获得吡咯烷-2-酮或3-碘吡咯，并且可以通过使用特定的氧化剂和添加剂容易地调节选择性。